Table 1.
Roles of KDM1A in oncogenesis
Type of cancer | KDM1A interactions | Functional role of KDM1A | References |
---|---|---|---|
Prostate cancer | Androgen receptor | ↓E-cadherin, ↑VEGF-A | [104, 105, 107] |
Breast cancer | Estrogen receptor (ERα), CAC2, β-catenin | ↓p57Kip2, ↓LEFTY1, ↓BRCA1 | [119, 120, 122–124] |
Oral cancer | E2F1 signaling pathway | ↑Cell proliferation | [130] |
Colorectal cancer | Wnt/β-catenin pathway | ↓DKK1, ↑LGR5 | [134, 135] |
Neuroblastoma | miR-137 | ↑Poorly differentiated cells | [111, 112] |
Glioblastoma | GSK3β | ↓BMP2, ↓CDKN1A, ↓GATA6 | [107, 114] |
Acute myeloid leukemia | MLL-AF9 | ↑Activation of oncogenes | [145] |
T-cell acute lymphoid leukemia | Notch signaling pathway, TAL1/SCL | ↑Activation and ↓repression of Notch target genes | [61, 62, 150] |
KDM1A interact with different signaling pathways and interacting partners. This interaction enables KDM1A to play role in development of different types of cancers. ↓ indicates the down regulation while ↑ denotes the upregulated expression of different genes and factors